Skip to main content
. Author manuscript; available in PMC: 2013 Jun 3.
Published in final edited form as: Cancer. 2010 Oct 1;116(19):4656–4663. doi: 10.1002/cncr.25217

Table 2.

Associations Between Treatment Site and End-of-Life Medical Care

Intensive Carea Hospice Servicesb Other EOL Carec
Treatment Site No./Total % OR 95% CI No./Total % OR 95% CI No./Total % OR 95% CI
Yale Cancer Center 9/75 12.0 3.14 1.16-8.47d 37/75 49.3 0.52 0.29-0.92d 29/75 38.7 0.63 0.34-1.15
Simmons Comprehensive
 Cancer Center
3/33 9.1 2.30 0.58-9.16 20/33 60.6 0.64 0.29-1.38 10/33 36.4 0.69 0.31-1.55
New Hampshire
 Oncology-Hematology
0/66 0 e e 50/66 75.8 1.66 0.85-3.24 16/66 24.2 1.24 0.63-2.45
Parkland Hospital 8/128 6.3 Ref Ref 84/128 65.6 Ref Ref 36/128 28.1 Ref Ref

EOL indicates end of life; OR, odds ratio; CI, confidence interval; Ref, referent category.

a

Defined as the receipt of cardiopulmonary resuscitation and/or mechanical ventilation followed by death in an intensive care unit.

b

Included patients who died either at home while receiving hospice services or in an inpatient hospice (n=40/191).

c

Other EOL care included inpatient hospital care (n=58; 5 patients received care in an intensive care unit and then were transferred to a hospital floor before death), home care without hospice services (n=20), and inpatient nursing home care (n=13).

d

P <.05 (significant).

e

No cases.